Fluconazole-resistant pathogens Candida inconspicua and C. norvegensis: DNA sequence diversity of the rRNA intergenic spacer region, antifungal drug susceptibility, and extracellular enzyme production

Microbiology and Immunology

Volumn 48, Issue 10, 2004, Pages 761-766

  Sugita, Takashi ^a   Takeo, Kanji ^b   Ohkusu, Misako ^b   Virtudazo, Eric ^b   Takashima, Masako ^c   Asako, Emi ^a   Ohshima, Fumiko ^a   Harada, Satoshi ^a   Yanaka, Chikako ^a   Nishikawa, Akemi ^a   Majoros, Laszlo ^d   Sipiczki, Matthias ^e  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c RIKEN BIORESOURCE CENTER   (Japan)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Candida inconspicua; Candida norvegensis; Drug susceptibility; Intergenic spacer region

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ASPARTIC PROTEINASE; FLUCONAZOLE; FLUCYTOSINE; FUNGAL ENZYME; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; LYSOPHOSPHOLIPASE; MICAFUNGIN; MICONAZOLE; RIBOSOME RNA; SPACER DNA; VIRULENCE FACTOR;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA INCONSPICUA; CANDIDA NORVEGENSIS; CONTROLLED STUDY; DNA SEQUENCE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME RELEASE; EUROPE; FUNGAL VIRULENCE; GENOTYPE; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY;

CANDIDA; CANDIDA INCONSPICUA; CANDIDA NORVEGENSIS; FUNGI; MYXOGASTRIA; PICHIA NORVEGENSIS;

EID: 7044224693     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03602.x     Document Type: Article

References (31)

1. Baily, G.G., Moore, C.B., Essayag, S.M., de Wit, S., Burnie, J.P., and Denning, D.W. 1997. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 25: 161-163.
2. Calderone, R., Suzuki, S., Cannon, R., Cho, T., Boyd, D., Calera, J., Chibana, H., Herman, D., Holmes, A., Jeng, H.W., Kaminishi, H., Matsumoto, T., Mikami, T., O'Sullivan, J.M., Sudoh, M., Suzuki, M., Nakashima, Y., Tanaka, T., Tompkins, G.R., and Watanabe, T. 2000. Candida albicans: adherence, signaling and virulence. Med. Mycol. 38: 125-137.
3. Carrega, G., Riccio, G., Santoriello, L., Pasqualini, M., and Pellicci, R. 1997. Candida famata fungemia in a surgical patient successfully treated with fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 16: 698-699.
4. D'Antonio, D., Violante, B., Mazzoni, A., Bonfini, T., Capuani, M.A., D'Aloia, F., Iacone, A., Schioppa, F., and Romano, F. 1998. A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies. J. Clin. Microbiol. 36: 792-795.
5. De Bernardis, F., Mondello, F., San Millan, R., Ponton, J., and Cassone, A. 1999. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J. Clin. Microbiol. 37: 3481-3486.
6. De Bernardis, F., Sullivan, P.A., and Cassone, A. 2001. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med. Mycol. 39: 303-313.
7. Ghannoum, M.A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13: 122-143.
8. Hazen, K.C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8: 462-478.
9. Levenson, D., Pfaller, M.A., Smith, M.A., Hollis, R., Gerarden, T., Tucci, C.B., and Isenberg, H.D. 1991. Candida zeylanoides: another opportunistic yeast. J. Clin. Microbiol. 29: 1689-1692.
10. Liu, H. 2001. Transcriptional control of dimorphism in Candida albicans. Curr. Opin. Microbiol. 4: 728-735.
11. Majoros, L., Kardos, G., Belak, A., Maraz, A., Asztalos, L., Csanky, E., Barta, Z., and Szabo, B. 2003. Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures. J. Clin. Microbiol. 41: 5250-5253.
12. Makimura, K., Murayama, S.Y., and Yamaguchi, H. 1994. Detection of a wide range of medically important fungi by the polymerase chain reaction. J. Med. Microbiol. 40: 358-364.
13. Marco, F., Lockhart, S.R., Pfaller, M.A., Pujol, C., Rangel-Frausto, M.S., Wiblin, T., Blumberg, H.M., Edwards, J.E., Jarvis, W., Saiman, L., Patterson, J.E., Rinaldi, M.G., Wenzel, R.P., and Soll, D.R. 1999. Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3. J. Clin. Microbiol. 37: 2817-2828.
14. Neumeister, B., Rockemann, M., and Marre, R. 1992. Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses 35: 309-310.
15. Nho, S., Anderson, M.J., Moore, C.B., and Denning, D.W. 1997. Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains. J. Clin. Microbiol. 35: 1036-1039.
16. Pfaller, M.A., Messer, S.A., Hollis, R.J., Jones, R.N., and Diekema, D.J. 2002. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemtic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob. Agents Chemother. 46: 1723-1727.
17. Pfaller, M.A., Diekema, D.J., Messer, S.A., Boyken, L., Hollis, R.J., and Jones, R.N. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41: 78-83.
18. Pietrucha-Dilanchian, P., Lewis, R.E., Ahmad, H., and Lechin, A.E. 2001. Candida lusitaniae catheter-related sepsis. Ann. Pharmacother. 35: 1570-1574.
19. Price, M.F., Wilkinson, I.D., and Gentry, L.O. 1982. Plate method for detection of phospholipase activity of Candida albicans. Sabouraudia 20: 7-14.
20. Rodero, L., Cuenca-Estrella, M., Cordoba, S., Cahn, P., Davel, G., Kaufman, S., Guelfand, L., and Rodriguez-Tudela, J.L. 2002. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J. Clin. Microbiol. 40: 2266-2269.
21. Sandven, P., Nilsen, K., Digranes, A., Tjade, T., and Lassen, J. 1997. Candida norvegensis: a fluconazole-resistant species. Antimicrob. Agents Chemother. 41: 1375-1376.
22. Schmid, J., Tay, Y.P., Wan, L., Carr, M., Parr, D., and Mc-Kinney, W. 1995. Evidence for nosocomial transmission of Candida albicans obtained by Ca3 fingerprinting. J. Clin. Microbiol. 33: 1223-1230.
23. Shin, J.H., Kook, H., Shin, D.H., Hwang, T.J., Kim, M., Suh, S.P., and Ryang, D.W. 2000. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients. Eur. J. Clin. Microbiol. Infect. Dis. 19: 344-349.
24. Soll, D.R. 1992. High-frequency switching in Candida albicans. Clin. Microbiol. Rev. 5: 183-203.
25. Sugar, A.M., and Stevens, D.A. 1985. Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature. Cancer 56: 318-320.
26. Sugita, T., Ikeda, R., and Shinoda, T. 2001. Diversity among strains of Cryptococcus neoformans var. gattii as revealed by a sequence analysis of multiple genes and a chemotype analysis of capsular polysaccharide. Microbiol. Immunol. 45: 757-768.
27. Sugita, T., Kodama, M., Saito, M., Ito, T., Kato, Y., Tsuboi, R., and Nishikawa, A. 2003. Sequence diversity of the intergenic spacer region of the rRNA gene of Malassezia globosa colonizing the skin of patients with atopic dermatitis and healthy individuals. J. Clin. Microbiol. 41: 3022-3027.
28. Sugita, T., Nakajima, M., Ikeda, R., Matsushima, T., and Shinoda, T. 2002. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J. Clin. Microbiol. 40: 1826-1830.
29. Sugita, T., Nishikawa, A., Ikeda, R., and Shinoda, T. 1999. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J. Clin. Microbiol. 37: 1985-1993.
30. Sugita, T., Takeo, K., Hama, K., Virtudaz, E., Takashima, M., Nishikawa, A., Kucsera, J., Dorogi, J., Komori, S., Nakagaki, K., Vollekova, A., Slovikova, E., and Farkas, V. 2004. DNA sequence diversity of intergenic spacer I region in the non-lipid-dependent species Malassezia pachydermatis isolated from animals. Med. Mycol. in press.
31. Vazquez, J.A., Arganoza, M.T., Boikov, D., Yoon, S., Sobel, J.D., and Akins, R.A. 1998. Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles. J. Clin. Microbiol. 36: 2690-2695.